Caleb Alexander, MD
- Associate Professor
- Division: Cardiovascular Disease and Clinical Epidemiology
- School of Medicine (Joint)
Center & Institute Affiliations
- Center for Drug Safety and Effectiveness
- Center for Health Services and Outcomes Research
- Center for Mental Health and Addiction Policy Research
- Center of Excellence in Regulatory Science and Innovation (CERSI)
615 N. Wolfe Street
Baltimore, Maryland 21205
410 955 0863
MS, University of Chicago, 2003
MD, Case Western Reserve University, 1998
Dr. Alexander is an Associate Professor of Epidemiology and Medicine at the Johns Hopkins Bloomberg School of Public Health, where he serves as founding co-Director of the Center for Drug Safety and Effectiveness and Principal Investigator of the Johns Hopkins-FDA Center of Excellence in Regulatory Science and Innovation (JH-CERSI). He is a practicing general internist and pharmacoepidemiologist and is internationally recognized for his research examining prescription drug utilization, safety and effectiveness. The author of over 200 scientific articles and book chapters, and he has published regularly in leading scientific journals, serves on several editorial and advisory boards and is a frequent speaker on pharmaceutical utilization and policy. In addition to expertise conducting survey-based investigations, Dr. Alexander also has extensive experience with the analysis of secondary data sources including administrative and pharmacy claims and large national surveys. Dr. Alexander received his B.A. cum laude from the University of Pennsylvania, an MD from Case Western Reserve University, and a Master of Science from the University of Chicago.
Research Interests: prescription drugs; drug utilization; drug safety; drug effectiveness; pharmacoepidemiology; pharmaceutical policy
Honors and Awards
1993 Cum Laude, University of Pennsylvania
1997 Alpha Omega Alpha, Case Western Reserve University
2011 Elected Fellow of the American College of Physicians (FACP)
2001 Edward W. Holmes Resident Research Award, University of Pennsylvania
2006-2009 Robert Wood Johnson Foundation Faculty Scholar
2007 Research Finalist, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting
2008 Outstanding Physician Scientist Award, Central Society for Clinical Research
2008 Career development award, Central Society for Clinical Research
2008 Department of Medicine Research Award (awarded to trainee for mentored research; also received by mentored trainees in 2009 and 2010)
2009 Pritzker School of Medicine Sigma Xi Award for Impact on Science (awarded to trainee for mentored research)
- prescription drugs
- drug utilization
- drug safety
- drug effectiveness
- patient-provider communication
- regulatory policy
- Food and Drug Administration
Select Scientific Publications (of over 200 total; trainees' names are underlined)
- Yin W, Basu A, Zhang J, Rabbani A, Meltzer DO, Alexander GC. Impact of the Medicare Part D Prescription Drug Benefit on drug utilization and out-of-pocket expenditures. Annals of Internal Medicine. 2008;148:169-177.
- Dorsey R, Rabbani A, Gallagher SA, Conti R, Alexander GC. The impact of black box warnings on the use of atypical antipsychotic medicines. Archives of Internal Medicine. 2010;170:96-103.
- Dusetzina SB, Higashi A (*co-first author), Dorsey ER, Conti R, Huskamp HA, Zhu S, Garfield CF, Alexander GC. Impact of FDA risk communications on health care utilization and health behaviors: a systematic review. Medical Care. 2012;50:466-78.
- Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC. National trends in oral anticoagulant use in the United States, 2007-2011. Circulation: Cardiovascular Outcomes and Quality. 2012;5:615-621.
- Daubresse M, Chang H-Y, Yu Y, Viswanathan S, Shah ND, Stafford RS, Kruszewski SP, Alexander GC. Ambulatory Diagnosis and Treatment of Non-Malignant Pain in the United States, 2000-2010. Medical Care. 2013;51:870-8.